Skip to main content
AtriCure, Inc. logo

AtriCure, Inc. — Investor Relations & Filings

Ticker · ATRC ISIN · US04963C2098 LEI · 254900B2I6GPHK2EXM59 US Manufacturing
Open in API
Filings indexed 1,189 across all filing types
Latest filing 2015-07-31 Interim / Quarterly Rep…
Country US United States of America
Listing US ATRC

About AtriCure, Inc.

https://www.atricure.com

AtriCure, Inc. is a medical device company focused on developing, manufacturing, and selling technologies for the treatment of atrial fibrillation (Afib), management of the left atrial appendage (LAA), and post-operative pain. The company's product portfolio is primarily utilized by cardiothoracic surgeons and electrophysiologists. Key offerings include surgical ablation systems and the AtriClip® LAA Exclusion System, a widely implanted device for LAA management. Additionally, AtriCure provides cryoablation technology, such as the cryoXT™ Probe, which offers a non-opioid approach to pain management following surgical procedures, including amputation.

Recent filings

Filing Released Lang Actions
QUARTERLY REPORT
Interim / Quarterly Report Q2 2015
2015-07-31 English
CURRENT REPORT
Earnings Release Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated July 28, 2015. It announces the issuance of a press release regarding the company's financial results for the second quarter ended June 30, 2015, and mentions a conference call to discuss these results. The document itself does not contain the financial results or detailed financial statements but rather furnishes the press release as an exhibit. The text explicitly states that the information is being furnished and shall not be deemed filed for certain regulatory purposes, indicating this is an announcement of financial results rather than the results themselves. Given the nature of the document as a brief announcement of quarterly financial results and a conference call, this fits the definition of an Earnings Release (ER). The document length is short (2921 characters), consistent with an initial announcement rather than a full report. Therefore, the appropriate classification is Earnings Release (ER).
2015-07-28 English
FORM 4 SUBMISSION
Director's Dealing
2015-07-02 English
FORM 4 SUBMISSION
Director's Dealing
2015-07-02 English
FORM 4 SUBMISSION
Director's Dealing
2015-07-02 English
FORM 4 SUBMISSION
Director's Dealing
2015-07-02 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.